CD47 Blockade Reprograms the Monocyte-Macrophage Axis to Promote Inflammation Resolution in Atherosclerosis
Murat Kırtay, Mikael Ispirjan, Benjamin Bonnard…·Kai-Uwe Jarr
This study shows CD47 blockade reprograms the monocyte-macrophage axis in atherosclerosis, reducing inflammation and enhancing apoptotic cell clearance.